www.einpresswire.com Open in urlscan Pro
173.203.102.50  Public Scan

Form analysis
2 forms found in the DOM

POST https://world.einnews.com/search

<form action="https://world.einnews.com/search" class="m-input-search js-hic-ignore" enctype="multipart/form-data" method="POST">
  <input class="a-input m-input-search__input" name="query" placeholder="News Search" required="" type="search">
  <input name="search_market" type="hidden" value="y">
  <input name="token" type="hidden">
  <button class="m-input-search__btn" type="submit">
    <svg class="icon icon-magnifying-glass m-input-search__icon">
      <use xlink:href="/images/2019/symbol-defs.svg#icon-magnifying-glass"></use>
    </svg>
  </button>
</form>

POST https://world.einnews.com/search

<form action="https://world.einnews.com/search" class="js-hic-ignore o-header__search-box m-box text-center" enctype="multipart/form-data" method="POST">
  <span class="m-box__title"> News Search </span>
  <input name="search_market" type="hidden" value="y">
  <input name="token" type="hidden">
  <input class="js-search-input-mobile m-box__input a-input" name="query" placeholder="News Search" type="search">
  <button class="a-button m-box__btn bg-red text-s" type="submit"> Search </button>
</form>

Text Content

 * About
   * About EIN Presswire
   * How We Are Different. Better
   * How It Works
   * Testimonials
   * Company Ethos
   * Contact
   * EIN Presswire in the News
 * Pricing
 * Distribution
   * Distribution Overview
   * Media Database
   * Major News Sites
   * U.S. TV & Radio Stations
   * U.S. & International Newswires
   * Newswires by Industry
   * Newswires by Country
   * Newswires by U.S. State
   * Mobile Apps
   * NewsPlugin
   * Live Feed
   * Sample Distribution Report
 * Press Releases
   * All
   * Featured
   * By Industry
   * By Country
   * By U.S. State
   * Archive
 * Newswires
   * U.S. & International Newswires
   * Newswires by Industry
      * Agriculture
      * Airline
      * Automotive
      * Banking
      * Book Publishing
      * Business
      * Casinos
      * Chemicals
      * Companies
      * Conferences & Trade Shows
      * Construction
      * Consumer
      * Cosmetics
      * Education
      * Electronics
      * Emergency Services
      * Energy
      * Environment
      * Food
      * Furniture
      * Healthcare
      * Hobbies
      * Human Rights
      * IT
      * Insurance
      * International Organizations
      * Law
      * Lifestyle
      * Manufacturing
      * Media
      * Military
      * Mining
      * Movie
      * Music
      * Natural Disasters
      * Politics
      * Religion
      * Real Estate
      * Retail
      * Science
      * Shipping & Logistics
      * Social Media
      * Sports
      * Technology
      * Telecom
      * Textiles
      * Tobacco
      * Travel
      * U.S. Politics
      * Waste Management
      * World News
   
   * Newswires by Country
      * Afghanistan
      * Alabama (US)
      * Alaska (US)
      * Albania
      * Algeria
      * Andorra
      * Angola
      * Argentina
      * Arizona (US)
      * Arkansas (US)
      * Armenia
      * Australia
      * Austria
      * Azerbaijan
      * Bahamas
      * Bahrain
      * Bangladesh
      * Barbados
      * Belarus
      * Belgium
      * Belize
      * Benin
      * Bermuda
      * Bhutan
      * Bolivia
      * Bosnia and Herzegovina
      * Botswana
      * Brazil
      * Brunei
      * Bulgaria
      * Burkina Faso
      * Burundi
      * California (US)
      * Cambodia
      * Cameroon
      * Canada
      * Cape Verde
      * Cayman Islands
      * Central African Republic
      * Chad
      * Chile
      * China
      * Colombia
      * Colorado (US)
      * Comoros
      * Congo-Brazzaville
      * Congo-Kinshasa
      * Connecticut (US)
      * Costa Rica
      * Croatia
      * Cuba
      * Cyprus
      * Czech Republic
      * Delaware (US)
      * Denmark
      * District of Columbia (US)
      * Djibouti
      * Dominican Republic
      * East Timor
      * Ecuador
      * Egypt
      * El Salvador
      * Equatorial Guinea
      * Eritrea
      * Estonia
      * Ethiopia
      * Falkland Islands
      * Fiji
      * Finland
      * Florida (US)
      * France
      * Gabon
      * Gambia
      * Georgia
      * Georgia (US)
      * Germany
      * Ghana
      * Gibraltar
      * Greece
      * Guam
      * Guatemala
      * Guinea
      * Guinea-Bissau
      * Guyana
      * Haiti
      * Hawaii (US)
      * Honduras
      * Hong Kong
      * Hungary
      * Iceland
      * Idaho (US)
      * Illinois (US)
      * India
      * Indiana (US)
      * Indonesia
      * Iowa (US)
      * Iran
      * Iraq
      * Ireland
      * Israel
      * Italy
      * Ivory Coast
      * Jamaica
      * Japan
      * Jordan
      * Kansas (US)
      * Kazakhstan
      * Kentucky (US)
      * Kenya
      * Kosovo
      * Kuwait
      * Kyrgyzstan
      * Laos
      * Latvia
      * Lebanon
      * Lesotho
      * Liberia
      * Libya
      * Liechtenstein
      * Lithuania
      * Louisiana (US)
      * Luxembourg
      * Madagascar
      * Maine (US)
      * Malawi
      * Malaysia
      * Mali
      * Malta
      * Maryland (US)
      * Massachusetts (US)
      * Mauritania
      * Mauritius
      * Mexico
      * Michigan (US)
      * Minnesota (US)
      * Mississippi (US)
      * Missouri (US)
      * Moldova
      * Monaco
      * Mongolia
      * Montana (US)
      * Montenegro
      * Morocco
      * Mozambique
      * Myanmar
      * Namibia
      * Nebraska (US)
      * Nepal
      * Netherlands
      * Nevada (US)
      * New Hampshire (US)
      * New Jersey (US)
      * New Mexico (US)
      * New York (US)
      * New Zealand
      * Nicaragua
      * Niger
      * Nigeria
      * North Carolina (US)
      * North Dakota (US)
      * North Korea
      * North Macedonia
      * Norway
      * Ohio (US)
      * Oklahoma (US)
      * Oman
      * Oregon (US)
      * Pakistan
      * Palestine
      * Panama
      * Papua New Guinea
      * Paraguay
      * Pennsylvania (US)
      * Peru
      * Philippines
      * Poland
      * Portugal
      * Puerto Rico
      * Qatar
      * Reunion
      * Rhode Island (US)
      * Romania
      * Russia
      * Rwanda
      * San Marino
      * Sao Tome and Principe
      * Saudi Arabia
      * Senegal
      * Serbia
      * Seychelles
      * Sierra Leone
      * Singapore
      * Slovakia
      * Slovenia
      * Somalia
      * South Africa
      * South Carolina (US)
      * South Dakota (US)
      * South Korea
      * South Sudan
      * Spain
      * Sri Lanka
      * Sudan
      * Suriname
      * Swaziland
      * Sweden
      * Switzerland
      * Syria
      * Taiwan
      * Tajikistan
      * Tanzania
      * Tennessee (US)
      * Texas (US)
      * Thailand
      * Togo
      * Tunisia
      * Turkey
      * Turkmenistan
      * Uganda
      * Ukraine
      * United Arab Emirates
      * United Kingdom
      * United States
      * Uruguay
      * Utah (US)
      * Uzbekistan
      * Vanuatu
      * Vatican City
      * Venezuela
      * Vermont (US)
      * Vietnam
      * Virginia (US)
      * Washington (US)
      * West Virginia (US)
      * Western Sahara
      * Wisconsin (US)
      * Wyoming (US)
      * Yemen
      * Zambia
      * Zimbabwe
   
   * Newswires by US State
      * Alabama
      * Alaska
      * Arizona
      * Arkansas
      * California
      * Colorado
      * Connecticut
      * Delaware
      * District of Columbia
      * Florida
      * Georgia
      * Hawaii
      * Idaho
      * Illinois
      * Indiana
      * Iowa
      * Kansas
      * Kentucky
      * Louisiana
      * Maine
      * Maryland
      * Massachusetts
      * Michigan
      * Minnesota
      * Mississippi
      * Missouri
      * Montana
      * Nebraska
      * Nevada
      * New Hampshire
      * New Jersey
      * New Mexico
      * New York
      * North Carolina
      * North Dakota
      * Ohio
      * Oklahoma
      * Oregon
      * Pennsylvania
      * Rhode Island
      * South Carolina
      * South Dakota
      * Tennessee
      * Texas
      * Utah
      * Vermont
      * Virginia
      * Washington
      * West Virginia
      * Wisconsin
      * Wyoming
   
   * Live Feed
 * Knowledge Base
   * Editorial Guidelines
   * Video Tutorials
   * How to Write Great Press Release
   * FAQs
   * RSS Feeds
   * Email Newsletters
   * News Alert Maker
   * Affiliate Program

 * Questions? +1 (202) 335-3939
 * Pricing & Comparison Chart
 * Contact
 * Log In

Submit Release
News Search Search



INNOVATIVE RESEARCH, INCLUSIVE TRIALS, AND NEW FUNDING DRIVES HOPE FOR PEOPLE
WITH PARKINSON'S DISEASE

News Provided By
Spokesperson, PhotoPharmics
November 15, 2023, 18:51 GMT
Share This Article



Kent Savage, CEO of PhotoPharmics



PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal
Clinical Trial for FDA Market Authorization


This investment is a pivotal moment in our journey to transform the treatment
landscape for Parkinson's disease.”
— Kent Savage, CEO

AMERICAN FORK, UT, UNITED STATES, November 15, 2023 /EINPresswire.com/ --
PhotoPharmics, an innovator in Parkinson's disease research and treatment, today
announced the successful first close of an $16 million investment round. The
investment round, led by Kickstart Fund, a venture capital firm based in Salt
Lake City, marks a significant milestone in PhotoPharmics' mission to
revolutionize Parkinson's disease treatment.

The primary purpose of this investment round is to fund a pivotal clinical trial
aimed at obtaining FDA market authorization for Celeste PhotoPharmics' FDA
breakthrough therapeutic device for Parkinson's disease. In research to this
point, the innovative therapy has shown remarkable potential in improving
overall function and quality of life for people with Parkinson's disease.

Kent Savage, CEO of PhotoPharmics, expressed his gratitude for the support of
investors, stating, "This investment is a pivotal moment in our journey to
transform the treatment landscape for Parkinson's disease. With this funding, we
are positioned to advance our research and bring hope to the millions of
individuals living with Parkinson's."

Kickstart’s expertise in supporting innovative ventures played a key role in
leading this investment round. Their commitment to PhotoPharmics reflects their
confidence in the potential of Celeste.

The Light for PD trial meets rigorous FDA and world-wide standards and will
assess the safety and efficacy of Celeste, a non-invasive treatment for
Parkinson's disease. Celest is designed to improve both motor and non-motor
function, offering a comprehensive non-pharmaceutical approach to Parkinson's
care.

Trial Description
---------------
The Light for PD trial will be a landmark study in the field of Parkinson's
disease treatment. This pivotal trial is designed to demonstrate Celeste's
potential to significantly enhance the lives of patients by targeting a range of
symptoms, including motor dysfunction, sleep disturbances, fatigue, mood
fluctuations, cognitive impairments, reduced activity levels, and disruptions in
circadian rhythm.

What sets this trial apart is its inclusive and accessible virtual design.
Participants will have the opportunity to engage from the comfort of their own
homes, eliminating geographical barriers and ensuring a diverse and
representative population. Celeste is used passively in the home and clinical
visits will be conducted via Zoom videoconferencing.

The investor’s commitments underscore the growing recognition of the potential
of Celeste to improve the lives of Parkinson's patients and reaffirms
PhotoPharmics' commitment to pushing the boundaries of innovation in the field
of neurodegenerative diseases.

About PhotoPharmics
---------------
PhotoPharmics is a privately held, clinical-stage medical device company
developing next-generation treatments for treating neurodegenerative disorders
through the eyes. Company founders have 30+ years of research and experience in
this field. They previously developed specialized light solutions now widely
used to regulate circadian rhythms in seasonal affective disorder, sleep
disorders, anxiety, and depression (acquired by Philips-Respironics in 2007).

Drawing from research and recent trials, PhotoPharmics is developing
applications of specialized phototherapy across several neurodegenerative
diseases. The company aims to make a clinically meaningful difference in
patients’ lives by delivering safe and effective non-invasive treatments.
Investor inquiries are welcomed. Learn more at www.photopharmics.com.
###

Spokesperson
PhotoPharmics
+1 801-361-6600
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram



You just read:


INNOVATIVE RESEARCH, INCLUSIVE TRIALS, AND NEW FUNDING DRIVES HOPE FOR PEOPLE
WITH PARKINSON'S DISEASE

News Provided By
Spokesperson, PhotoPharmics
November 15, 2023, 18:51 GMT
Share This Article


Distribution channels: Banking, Finance & Investment Industry, Business &
Economy, Companies, Culture, Society & Lifestyle, Healthcare & Pharmaceuticals
Industry


EIN Presswire's priority is source transparency. We do not allow opaque clients,
and our editors try to be careful about weeding out false and misleading
content. As a user, if you see something we have missed, please do bring it to
our attention. Your help is welcome. EIN Presswire, Everyone's Internet News
Presswire™, tries to define some of the boundaries that are reasonable in
today's world. Please see our Editorial Guidelines for more information.

Contact
Spokesperson
PhotoPharmics
+1 801-361-6600



--------------------------------------------------------------------------------

PR Distribution
 * How It Works
 * Why Us
 * Pricing
 * Distribution
 * Editorial Guidelines

Submit Release

--------------------------------------------------------------------------------

Newswires
 * All Newswires
 * World Newswires
 * US Newswires
 * Industry Newswires

--------------------------------------------------------------------------------

Press Releases
 * All Press Releases
 * Releases by Country
 * Releases by US State
 * Releases by Industry
 * Releases by Date

--------------------------------------------------------------------------------

Resources
 * World Media Directory
 * Mobile App
 * Affiliate Program
 * RSS Feeds
 * Email Newsletters
 * News Alert Maker
 * NewsPlugin

--------------------------------------------------------------------------------

Help/Support
 * FAQ
 * Video Tutorials
 * Client Testimonials

--------------------------------------------------------------------------------

About
 * About EIN Presswire
 * Newsroom
 * Investor Inquiries
 * Career Opportunities
 * Contact



Follow EIN Presswire

--------------------------------------------------------------------------------

 * User Agreement
 * Privacy Policy
 * Copyright Policy

© 1995-2023 Newsmatics Inc. dba EIN Presswire
All Right Reserved.

We use cookies for analytics, personalized content and ads. By continuing to
browse this site, you agree to this use. Learn more ×